These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
383 related items for PubMed ID: 16924648
1. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. Lanzkron S, Haywood C, Segal JB, Dover GJ. Am J Hematol; 2006 Dec; 81(12):927-32. PubMed ID: 16924648 [Abstract] [Full Text] [Related]
2. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. Stallworth JR, Jerrell JM, Tripathi A. Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429 [Abstract] [Full Text] [Related]
4. Examining the effectiveness of hydroxyurea in people with sickle cell disease. Lanzkron S, Haywood C, Fagan PJ, Rand CS. J Health Care Poor Underserved; 2010 Feb; 21(1):277-86. PubMed ID: 20173269 [Abstract] [Full Text] [Related]
6. Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia. Wang WC, Oyeku SO, Luo Z, Boulet SL, Miller ST, Casella JF, Fish B, Thompson BW, Grosse SD, BABY HUG Investigators. Pediatrics; 2013 Oct; 132(4):677-83. PubMed ID: 23999955 [Abstract] [Full Text] [Related]
7. Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Moore RD, Charache S, Terrin ML, Barton FB, Ballas SK. Am J Hematol; 2000 May; 64(1):26-31. PubMed ID: 10815784 [Abstract] [Full Text] [Related]
8. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Charache S. Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197 [Abstract] [Full Text] [Related]
11. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia. Vicari P, Barretto de Mello A, Figueiredo MS. Am J Hematol; 2005 Mar; 78(3):243-4. PubMed ID: 15726590 [Abstract] [Full Text] [Related]
12. Use of hydroxyurea in children with sickle cell disease: what comes next? Ohene-Frempong K, Smith-Whitley K. Semin Hematol; 1997 Jul; 34(3 Suppl 3):30-41. PubMed ID: 9317199 [Abstract] [Full Text] [Related]
13. Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease. Jain DL, Sarathi V, Desai S, Bhatnagar M, Lodha A. Hemoglobin; 2012 Jul; 36(4):323-32. PubMed ID: 22734586 [Abstract] [Full Text] [Related]
14. Bone marrow transplantation or hydroxyurea for sickle cell anemia: long-term effects on semen variables and hormone profiles. Lukusa AK, Vermylen C, Vanabelle B, Curaba M, Brichard B, Chantrain C, Dupont S, Ferrant A, Wyns C. Pediatr Hematol Oncol; 2009 Jun; 26(4):186-94. PubMed ID: 19437321 [Abstract] [Full Text] [Related]